-- 四川百奥金制药（SHA:688506）公布，预计2025年净利润将同比下降128%，从上年的37.1亿元人民币降至10.5亿元人民币。 该公司周二在上海证券交易所提交的文件中表示，每股收益将从9.25元人民币暴跌至2.61元人民币。 营收也大幅下滑57%，从58.2亿元人民币降至25.2亿元人民币。 百奥金将业绩不佳归咎于较高的基数，因为2024年的营收受益于与百时美施贵宝（BMS）就一款名为Iza-bren的产品达成的知识产权合作协议。 该公司股价在近期交易中下跌了3%。
Related Articles
Asia
Raytron Tech's Q1 Profit Surges 228%, Revenue Jumps 71%; Shares Up 5%
Raytron Technology's (SHA:688002) net profit attributable to shareholders in the first quarter surged 228% to 478.7 million yuan from 145.8 million yuan a year earlier, according to a Shanghai bourse filing on Tuesday.Earnings per share soared 211% year on year to 0.98 yuan from 0.32 yuan.Operating revenue jumped 71% to 1.94 billion yuan from 1.14 billion yuan in the prior year.Raytron manufactures uncooled infrared thermal imaging products. Its shares jumped 5% during the afternoon trade.
$SHA:688002
Asia
Jefferies Adjusts Perfect World's Price Target to 19.80 Yuan from 20.60 Yuan, Keeps at Buy
$SHE:002624
Asia
BP Plastics Strikes Off Dormant Unit; Shares Drop 3%
BP Plastics (KLSE:BPPLAS) unit BPPLAS Plantation has been struck off and deemed dissolved from the Companies Commission of Malaysia, according to a Monday Malaysian bourse filing.Shares fell about 3% in Tuesday's midday trade.BPPLAS Plantation was dormant with no future business plans, was dissolved as part of a cost and administrative streamlining exercise.The group said the dissolution will not have a material impact on earnings or net assets.
$KLSE:BPPLAS